Susan Kalled
Corporate Officer/Principal chez American Association for the Advancement of Science
Profil
Susan Kalled is a member of the American Association for the Advancement of Science, the New York Academy of Sciences, and The American Association of Immunologists.
She previously held positions as the Head-External Sciences at Shire, Inc. and Vice President-Biology at Q32 Bio, Inc. In 2021, she served as the Chief Scientific Officer at Compass Therapeutics, Inc. Dr. Kalled holds a doctorate degree from Tufts University and an undergraduate degree from the University of New Hampshire.
Postes actifs de Susan Kalled
Sociétés | Poste | Début |
---|---|---|
American Association for the Advancement of Science
American Association for the Advancement of Science Miscellaneous Commercial ServicesCommercial Services The American Association for the Advancement of Science provides science related journal, program, and education services. The firm also promotes the responsible use of science in public policy. The company was founded in 1848 and is headquartered in Washington, DC. | Corporate Officer/Principal | - |
The American Association of Immunologists | Corporate Officer/Principal | - |
New York Academy of Sciences
New York Academy of Sciences Miscellaneous Commercial ServicesCommercial Services New York Academy of Sciences is an independent, not-for-profit organization, which engages in the advancement of scientific research, education, and policy. The company was founded in 1817 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Anciens postes connus de Susan Kalled
Sociétés | Poste | Fin |
---|---|---|
COMPASS THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 29/11/2022 |
Shire, Inc.
Shire, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire, Inc. develops and markets medicines for patients with rare diseases. The company is based in Lexington, KY. | Corporate Officer/Principal | - |
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Formation de Susan Kalled
Tufts University | Doctorate Degree |
University of New Hampshire | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
COMPASS THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 5 |
---|---|
American Association for the Advancement of Science
American Association for the Advancement of Science Miscellaneous Commercial ServicesCommercial Services The American Association for the Advancement of Science provides science related journal, program, and education services. The firm also promotes the responsible use of science in public policy. The company was founded in 1848 and is headquartered in Washington, DC. | Commercial Services |
New York Academy of Sciences
New York Academy of Sciences Miscellaneous Commercial ServicesCommercial Services New York Academy of Sciences is an independent, not-for-profit organization, which engages in the advancement of scientific research, education, and policy. The company was founded in 1817 and is headquartered in New York, NY. | Commercial Services |
The American Association of Immunologists | |
Shire, Inc.
Shire, Inc. Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire, Inc. develops and markets medicines for patients with rare diseases. The company is based in Lexington, KY. | Health Technology |
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | Health Technology |